Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma

Table 3

Expression rates of the studied markers.

Marker	n (%)
CD44
Low	12 (22.6%)
Moderate	8 (15.1%)
High	33 (62.3%)
Ki67
Nil	1 (1.9%)
Low	23 (43.4%)
High	29 (54.7%)
Vimentin
Negative	21 (39.6%)
Positive	32 (60.4%)